World Hepatitis Day 2022

With a person dying every 30 seconds from a hepatitis related illness – we can’t wait to act on viral hepatitis.

World Hepatitis Day is on 28 July, and this year the theme is ‘I Can’t Wait’.

The campaign video “I Can’t Wait” shows people from across the world, from Thailand to Uganda, telling us why they can’t wait for a world without hepatitis.

About the campaign

The campaign will highlight the need to accelerate the fight against viral hepatitis and the importance of testing and treatment for the real people who need it. It will amplify the voices of people affected by viral hepatitis calling for immediate action and the end of stigma and discrimination.

Alongside this, it will also highlight the social injustice and inequity caused by the current lack of action on hepatitis elimination and focus on the positive action needed to get on track to meet our 2030 elimination goals.

The campaign will bring WHA and our global network of 318 members in 100 countries together to lead the campaign internationally to eliminate hepatitis by 2030.

Get involved

Whether you have one minute or an hour, there are plenty of ways you can get involved in World Hepatitis Day to make sure that the world knows that Hepatitis Can’t Wait!

Join our virtual global relay by submitting a 30 second video explaining what the elimination of viral hepatitis means to you.

Point to the time to show the urgent need for action on viral hepatitis. 

Download our campaign materials to raise awareness!

We can’t wait for a world without hepatitis, together we can make it happen.

www.worldhepatitisday.org

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close